Sittner & Nelson LLC Has $121,000 Stake in CVS Health Co. (NYSE:CVS)

Sittner & Nelson LLC lifted its holdings in CVS Health Co. (NYSE:CVS) by 152.4% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,918 shares of the pharmacy operator’s stock after acquiring an additional 1,158 shares during the quarter. Sittner & Nelson LLC’s holdings in CVS Health were worth $121,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of CVS. Norden Group LLC grew its holdings in CVS Health by 10.7% during the 1st quarter. Norden Group LLC now owns 6,830 shares of the pharmacy operator’s stock worth $545,000 after acquiring an additional 660 shares during the last quarter. GSA Capital Partners LLP acquired a new stake in shares of CVS Health in the first quarter valued at approximately $536,000. Advisory Alpha LLC raised its position in CVS Health by 9.6% in the 1st quarter. Advisory Alpha LLC now owns 3,753 shares of the pharmacy operator’s stock worth $299,000 after purchasing an additional 329 shares during the last quarter. Envestnet Portfolio Solutions Inc. boosted its position in CVS Health by 15.8% in the 1st quarter. Envestnet Portfolio Solutions Inc. now owns 148,361 shares of the pharmacy operator’s stock valued at $11,833,000 after buying an additional 20,264 shares during the last quarter. Finally, SG Americas Securities LLC boosted its position in CVS Health by 341.8% in the 1st quarter. SG Americas Securities LLC now owns 203,103 shares of the pharmacy operator’s stock valued at $16,199,000 after buying an additional 157,133 shares during the last quarter. 80.66% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

CVS has been the topic of a number of recent research reports. Truist Financial increased their price objective on CVS Health from $66.00 to $76.00 and gave the company a “buy” rating in a research report on Friday, October 11th. Cantor Fitzgerald reiterated a “neutral” rating and issued a $62.00 price objective on shares of CVS Health in a research report on Tuesday, October 1st. Wells Fargo & Company decreased their price objective on CVS Health from $61.00 to $60.00 and set an “equal weight” rating on the stock in a research report on Monday. Deutsche Bank Aktiengesellschaft decreased their price objective on CVS Health from $64.00 to $63.00 and set a “hold” rating on the stock in a research report on Friday, August 9th. Finally, Evercore ISI raised their price target on CVS Health from $62.00 to $75.00 and gave the stock an “outperform” rating in a research report on Tuesday, October 8th. Nine analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $73.00.

CVS Health Trading Down 7.3 %

Shares of NYSE:CVS opened at $57.11 on Friday. The company has a market capitalization of $71.84 billion, a P/E ratio of 14.49, a P/E/G ratio of 0.82 and a beta of 0.55. CVS Health Co. has a 1 year low of $52.77 and a 1 year high of $83.25. The company has a debt-to-equity ratio of 0.83, a current ratio of 0.86 and a quick ratio of 0.66. The business’s 50 day simple moving average is $59.59 and its 200 day simple moving average is $59.23.

CVS Health (NYSE:CVS) last issued its earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share for the quarter, beating analysts’ consensus estimates of $1.08 by $0.01. The firm had revenue of $95.43 billion for the quarter, compared to the consensus estimate of $92.72 billion. CVS Health had a return on equity of 12.72% and a net margin of 1.98%. The company’s revenue was up 6.3% compared to the same quarter last year. During the same quarter last year, the business posted $2.21 EPS. On average, research analysts anticipate that CVS Health Co. will post 6.27 EPS for the current fiscal year.

CVS Health Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, November 1st. Stockholders of record on Monday, October 21st were paid a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.66%. The ex-dividend date of this dividend was Monday, October 21st. CVS Health’s payout ratio is 67.51%.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.